Combining the transcriptomic profile of skin samples with metabolomic data in serum, the role of Lipoxygenases (LOX) and cyclooxygenase (COX) pathways for PUFA metabolism were determined in AD patients. This evidence concerns the gene LOX and Alzheimer disease.